Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 21Leukemia, Myeloid, Acute 16Lymphoma 15Leukemia 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Multiple Myeloma 13Lymphoma, Non-Hodgkin 13Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Follicular 12Hodgkin Disease 12Lymphoma, Mantle-Cell 9Lymphoma, Large B-Cell, Diffuse 8Lymphoma, B-Cell, Marginal Zone 8Graft vs Host Disease 8Neoplasms, Plasma Cell 7Leukemia, Myelomonocytic, Chronic 7Leukemia, Myeloid, Accelerated Phase 7Congenital Abnormalities 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Myeloproliferative Disorders 6Leukemia, Myeloid, Chronic-Phase 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Burkitt Lymphoma 6Blast Crisis 6Waldenstrom Macroglobulinemia 5Primary Myelofibrosis 5Myelodysplastic-Myeloproliferative Diseases 5Lymphoma, Large-Cell, Anaplastic 5Leukemia, Prolymphocytic 5Hematologic Neoplasms 5

Interventions

Cyclophosphamide 4Rituximab 3cobomarsen 2Vincristine 2Prednisone 2Etoposide 2Doxorubicin 2thymoglobulin 1ponatinib 1ibritumomab tiuxetan 1fludarabine phosphate 1fludarabine 1Vorinostat 1Tacrolimus 1Mycophenolic Acid 1Melphalan 1Imatinib Mesylate 1Ifosfamide 1Cytarabine 1Carmustine 1Carboplatin 1Busulfan 1Brentuximab Vedotin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Immune System Diseases × Tacrolimus × Clear all
NCT02627573 2019-04-05

Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT

St. Petersburg State Pavlov Medical University

Phase 2 Terminated
32 enrolled
MyeloidOther hematologic neoplasm

Immune System Diseases, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡